ACN Newswire China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global l CMS was included into the first "Sustainability Yearbook (China)" published by S&P Global.l Nearly 1600 Chinese companies were included in the selection pool, but only 88 companies, including CMS,
ACN Newswire 33rd Hong Kong Book Fair opens on 19 July HONG KONG, Jun 29, 2023 - (ACN Newswire) - The 33rd HKTDC Hong Kong Book Fair, organised by the Hong Kong Trade Development Council (HKTDC), will run from 19 to 25 July (Wednesday
ACN Newswire Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily NEW YORK, Jun 29, 2023 - (ACN Newswire) - Soligenix, Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical
JCN Newswire FREED GROUP Expands Global Reach with Key Stakeholder Investment in Gabi Partners HONG KONG, Jun 29, 2023 - (JCN Newswire) - FREED GROUP ("FREED"), an award-winning digital and smart merchandising solutions company founded and headquartered in Hong Kong, has announced the integration of Gabi Partners,
ACN Newswire Solar Powered Sunscreen: EcoZinc a World First in Sustainable Zinc Oxide Innovation BRISBANE, AUS, Jun 29, 2023 - (ACN Newswire) - Advance ZincTek, Australia's leading manufacturer of natural Sunscreen Actives, announces the launch of EcoZinc, the world's first solar-powered, non-nano zinc oxide powder for SPF-rated
ACN Newswire Solar Powered Sunscreen: EcoZinc a World First in Sustainable Zinc Oxide Innovation BRISBANE, AUS, Jun 29, 2023 - (亞太商訊) - Advance ZincTek, Australia's leading manufacturer of natural Sunscreen Actives, announces the launch of EcoZinc, the world's first solar-powered, non-nano zinc oxide powder for SPF-rated cosmetics
ACN Newswire NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun SHELTON, CT, Jun 29, 2023 - (亞太商訊) - NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral
ACN Newswire NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun SHELTON, CT, Jun 29, 2023 - (ACN Newswire) - NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two
ACN Newswire FREED GROUP对Gabi Partners进行关键利益相关者投资 拓展全球业务范围 HONG KONG, Jun 29, 2023 - (亚太商讯) - 在香港成立并以此作总部的电子商务解决方案公司FREED GROUP（”FREED”）屡获殊荣，于今日宣布与南韩领先会员制商务及供应链管理服务供应商Gabi Partners的业务整合。此战略性的举措不仅进一步巩固FREED在蓬勃发展的南韩市场的领导地位，更为其后续扩大全球市场做铺垫。FREED GROUP联合创办人兼行政总裁Abel Zhao先生（右）及Gabi Partners联合创办人兼行政总裁Siyoon Song先生（左）在南韩会面，象征美好的合作前景。（从左至右）FREED GROUP联合创办人兼首席产品官 Kenneth Lee先生；Gabi Partners
ACN Newswire FREED GROUP Expands Global Reach with Key Stakeholder Investment in Gabi Partners HONG KONG, Jun 29, 2023 - (ACN Newswire) - FREED GROUP ("FREED"), an award-winning digital and smart merchandising solutions company founded and headquartered in Hong Kong, has announced the integration of Gabi Partners,
ACN Newswire FREED GROUP對Gabi Partners進行關鍵利益相關者投資 拓展全球業務範圍 HONG KONG, Jun 29, 2023 - (亞太商訊) - 在香港成立並以此作總部的數碼商務解決方案公司FREED GROUP（「FREED」）屢獲殊榮，於今日宣布與南韓領先會員制商務及供應鏈管理服務供應商Gabi Partners的業務整合。此策略舉措不僅進一步鞏固FREED在蓬勃發展的南韓市場的領導地位，更為其擴大全球商機鋪路。FREED GROUP聯合創辦人兼行政總裁Abel Zhao先生（右）及Gabi Partners聯合創辦人兼行政總裁Siyoon Song先生（左）在南韓會面，象徵美好的合作前景。（從左至右）FREED GROUP聯合創辦人兼首席產品官 Kenneth Lee先生；Gabi Partners
JCN Newswire Honda Issues "Honda ESG Data Book 2023" TOKYO, Jun 29, 2023 - (JCN Newswire) - Honda Motor Co., Ltd. today issued its first "Honda ESG Data Book 2023," and made it available on the company website.Disclosure materialFor a diverse
JCN Newswire Hitachi Receives Orders for 160 Elevators, Escalators, Moving Sidewalks and Related Systems for the Hong Kong West Kowloon Station Complex TOKYO, Jun 29, 2023 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501), today announced that Hitachi Elevator Engineering Company (Hong Kong) Limited ("Hitachi Elevator Engineering (Hong Kong)"), a sales and service company for
JCN Newswire Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange HONG KONG, Jun 29, 2023 - (JCN Newswire) - A biotechnology company in China - Laekna, Inc. (stock code: 2105.HK), today listed on the Main Board of The Stock Exchange of Hong
ACN Newswire 日清食品收购日清越南及向其注资 HONG KONG, Jun 29, 2023 - (亚太商讯) - 日清食品有限公司（「日清食品」，连同其附属公司统称「集团」；股份代号：1475）与Nissin Foods Asia Co., Ltd.(1) （「卖方」）订立资本转让协议，据此，集团已同意购买指定投入资本(2)，以代价约为9.5百万美元收购日清食品（越南）有限公司（「日清越南」），并于收购事项完成后向日清越南注资2.0百万美元。就收购事项及注资应付的总代价约为11.
JCN Newswire MHI Hosts Successful CO2 Capture Plants User Conference in Bahrain TOKYO, Jun 29, 2023 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) held a user conference on May 17-18 in Manama, the capital of Bahrain, mainly for customers who have adopted MHI's
ACN Newswire 日清食品收購日清越南及向其注資 HONG KONG, Jun 29, 2023 - (亞太商訊) - 日清食品有限公司（「日清食品」，連同其附屬公司統稱「集團」；股份代號：1475）與Nissin Foods Asia Co., Ltd. (1)（「賣方」）訂立資本轉讓協議，據此，集團已同意購買指定投入資本(2)，以代價約為9.5百萬美元收購日清食品（越南）有限公司（「日清越南」），並於收購事項完成後向日清越南注資2.0百萬美元。就收購事項及注資應付的總代價約為11.
ACN Newswire Nissin Foods Acquires and Contributes Capital to Nissin Vietnam HONG KONG, Jun 29, 2023 - (ACN Newswire) - Nissin Foods Company Limited ("Nissin Foods", together with its subsidiaries, the "Group"; Stock code: 1475) has signed a Capital Transfer Agreement with Nissin Foods
JCN Newswire Mitsubishi Shipbuilding and NYK Line Obtain Approval in Principle (AiP) from Japan's Classification Society ClassNK for Ammonia and LCO2 Carrier TOKYO, Jun 29, 2023 - (JCN Newswire) - Mitsubishi Shipbuilding Co., Ltd., a part of the Mitsubishi Heavy Industries (MHI) Group, and Nippon Yusen Kabushiki Kaisha (NYK Line) have been granted Approval in
JCN Newswire BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development HEIDLEBERG, Germany, Jun 29, 2023 - (JCN Newswire) - BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine
ACN Newswire BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development HEIDLEBERG, Germany, Jun 29, 2023 - (ACN Newswire) - BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine
ACN Newswire BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development HEIDLEBERG, Germany, Jun 29, 2023 - (亞太商訊) - BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for
ACN Newswire 文化傳信全年業績毛利率大增 積極重組架構 拓展AI冀成增長動力 HONG KONG, Jun 29, 2023 - (亞太商訊) - 文化傳信集團有限公司（「文化傳信」、「集團」，股份編號：00343.HK）公布截至2023年3月31日止年度業績。受持續的2019冠狀病毒病疫症對業務造成不利影響，導致新業務發展放緩或延誤，集團錄得總收入3,060萬元，較上年度的6,237萬元減少；虧損由上年度2,894萬元，擴至3,722萬元。而毛利率大幅改善12.5個百分點至47.4%，主要得益於成本控制有效，以及數碼化市場推廣分部採取新推廣策略。集團繼上一個財政年度開始，已積極重組架構，精簡及合併數碼化市場推廣業務，
ACN Newswire 中国生物医药科技公司来凯医药于香港联合交易所主板成功上市 HONG KONG, Jun 29, 2023 - (亚太商讯) - 中国生物医药科技公司——来凯医药有限公司 (股份代号：2105.HK)，今天于香港联合交易所有限公司（“香港交易所”）主板上市。鸣锣开市来凯医药有限公司创始人、董事长兼首席执行官吕向阳博士致辞来凯医药本次全球发售63,728,000股股份，发行价格为每股12.41港元。所得款项净额将用于：(1) 迅速推进公司核心产品之一LAE001的临床开发及批准。(2) 推进公司另一核心产品LAE002的临床开发及批准。(3) 加快其他现有管线产品的研发，并不断推进及改进公司的管线产品。(4) 提高产能及发展制造能力。(5)
ACN Newswire 中國生物醫藥科技公司來凱醫藥於香港聯合交易所主板成功上市 HONG KONG, Jun 29, 2023 - (亞太商訊) - 中國生物醫藥科技公司——來凱醫藥有限公司 (股份代號：2105.HK)，今天於香港聯合交易所有限公司（「香港交易所」）主板上市。鳴鑼開市來凱醫藥有限公司創始人、董事長兼首席執行官呂向陽博士致辭來凱醫藥本次全球發售63,728,000股股份，發行價格為每股12.41港元。所得款项淨額將用於：(1) 迅速推進公司核心產品之一LAE001的臨床開發及批准。(2) 推進公司另一核心產品LAE002的臨床開發及批准。(3) 加快其他現有管線產品的研發，並不斷推進及改進公司的管線產品。(4) 提高產能及發展製造能力。(5)
